Does mild COPD affect prognosis in the elderly?

[1]  N. Roche,et al.  FEV1/FVC and FEV1 for the assessment of chronic airflow obstruction in prevalence studies: do prediction equations need revision? , 2008, Respiratory medicine.

[2]  M. Decramer,et al.  A 4-year trial of tiotropium in chronic obstructive pulmonary disease. , 2008, The New England journal of medicine.

[3]  J Stocks,et al.  Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction , 2008, Thorax.

[4]  B. Celli,et al.  Predictors of Survival in COPD: more than just the FEV1. , 2008, Respiratory medicine.

[5]  N. Probst-Hensch,et al.  Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD , 2008, Thorax.

[6]  C. Schindler,et al.  Reference equations for lung function screening of healthy never-smoking adults aged 18–80 years , 2008, European Respiratory Journal.

[7]  K. Overvad,et al.  The Prevalence of Chronic Obstructive Pulmonary Disease among Danes Aged 45–84 Years: Population-based Study , 2008, COPD.

[8]  B. Celli,et al.  Differences in cardiopulmonary exercise test results by American Thoracic Society/European Respiratory Society-Global Initiative for Chronic Obstructive Lung Disease stage categories and gender. , 2007, Chest.

[9]  H. Melbye,et al.  Lung function testing in the elderly - Can we still use FEV1/FVC < 70% as a criterion of COPD? , 2007 .

[10]  Bartolome Celli,et al.  Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. , 2007, The New England journal of medicine.

[11]  William M Vollmer,et al.  Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? , 2006, Thorax.

[12]  K. Wood,et al.  FEV1/FVC ratio of 70% misclassifies patients with obstruction at the extremes of age. , 2006, Chest.

[13]  H. Melbye,et al.  Lung function testing in the elderly--can we still use FEV1/FVC<70% as a criterion of COPD? , 2006, Respiratory medicine.

[14]  A. Lindberg,et al.  Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies. , 2006, Respiratory medicine.

[15]  J. Hankinson,et al.  Interpretative strategies for lung function tests , 2005, European Respiratory Journal.

[16]  A. Lindberg,et al.  Prevalence of Chronic Obstructive Pulmonary Disease according to BTS, ERS, GOLD and ATS Criteria in Relation to Doctor’s Diagnosis, Symptoms, Age, Gender, and Smoking Habits , 2005, Respiration.

[17]  P. Nilsson,et al.  Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis , 2005, Respiratory research.

[18]  W. MacNee,et al.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.

[19]  Ciro Casanova,et al.  The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.

[20]  D. Shaw,et al.  Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist , 2003, Thorax.

[21]  B. Celli,et al.  Population impact of different definitions of airway obstruction , 2003, European Respiratory Journal.

[22]  David B. Holiday,et al.  6-minute walk work for assessment of functional capacity in patients with COPD. , 2003, Chest.

[23]  D. Coultas,et al.  The health impact of undiagnosed airflow obstruction in a national sample of United States adults. , 2001, American journal of respiratory and critical care medicine.

[24]  S J Jay,et al.  Reference equations for the six-minute walk in healthy adults. , 2000 .

[25]  F. Rengo,et al.  Quality control of spirometry in the elderly. The SA.R.A. study. SAlute Respiration nell'Anziano = Respiratory Health in the Elderly. , 2000, American journal of respiratory and critical care medicine.

[26]  John L. Hankinson,et al.  Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[27]  T. W. van der Mark,et al.  Relation of lung function, maximal inspiratory pressure, dyspnoea, and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease. , 1994, Thorax.

[28]  D. Mannino,et al.  Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. , 2006, Respiratory medicine.